Table 1. Sero-prevalence of tetanus antibody protection at enrollment.
Days since tetanus toxoid vaccination | ||||
---|---|---|---|---|
0 | 14 | 28 | 42 | |
N (%) | N (%) | N (%) | N (%) | |
Total, N | 620 (100) | 237 (100) | 213 (100) | 147 (100) |
Interpretation: Laboratory results | ||||
Insufficient immunity | 354 (57.0) | 17(7.3) | 8 (3.8) | 0 |
Need booster | 153 (24.7) | 18 (7.6) | 9(4.2) | 0 |
Booster needed 2–5 years | 53 (8.5) | 8 (3.4) | 14 (6.6) | 6 (4.1) |
Booster needed 5–10 years | 39(6.3) | 35 (14.8) | 44 (20.7) | 38 (25.9) |
Booster needed over 10 years | 21 (3.4) | 159 (67.1) | 138 (64.8) | 103 (70.1) |